CN1301736C - Poriasis treating Chinese medicine - Google Patents
Poriasis treating Chinese medicine Download PDFInfo
- Publication number
- CN1301736C CN1301736C CNB2004100440258A CN200410044025A CN1301736C CN 1301736 C CN1301736 C CN 1301736C CN B2004100440258 A CNB2004100440258 A CN B2004100440258A CN 200410044025 A CN200410044025 A CN 200410044025A CN 1301736 C CN1301736 C CN 1301736C
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- present
- chinese medicine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses a traditional Chinese drug for treating psoriasis, which is prepared by grinding the crude drugs of the weight distribution ratio of 15 to 20% of alkanna tinctoria, 2 to 5% of antelope horn 5 to 10% of stir-frying rhubarb, 25 to 30% of rehmannia root, 25 to 30% of garter snake, 5 to 10% of cicada slough, 5 to 10% of dragon blood and 5 to 10% of scorpion into powder; other ordinary oral preparations can also be prepared. The traditional Chinese drug for treating psoriasis of the present invention has the effects of expelling wind, clearing away heat, removing heat from the blood and toxic substances, dispersing blood stasis and dredging channels. The present invention has the advantages of short course of treatment, obvious effect, no toxic or side effect, stable effect and no recurrence; the total effective rate can reach 98%.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to the psoriatic Chinese medicine of a kind of treatment.
Background technology
Psoriasis claims psoriasis again, and its clinical manifestation is how hemorrhage with erythema, pimple, congestion, pruritus incrustation, chapped skin, pain, and comes off with a large amount of silvery whites or Lycoperdon polymorphum Vitt scurf.On the human health development history, psoriasis is having a strong impact on people's healthy and orthobiosis, and it is desquamation layer by layer, very itches unbearably erythema sheet sheet, outbreak repeatedly.Though psoriasis is threat to life not, but prolonged controlling do not sent out better in exposed position, as positions such as head, extremity, shirtfront, back, often make the normal person that the patient is produced detest, patient's body and mind is formed very big pressure, have a strong impact on life, work and social communication, 35% may hereditary offspring so that many patients feel depressed, agonizing.At present the psoriatic Chinese medicine and western medicine of treatment has a variety ofly, but ubiquity course of treatment is long, slow, toxic side effect, Fa Zuo characteristics repeatedly take effect.
Summary of the invention
The object of the present invention is to provide a kind of short treating period, instant effect, have no side effect, be difficult for the Chinese medicine of the treatment psoriasis vulgaris of recurrence.
Chinese medicine of the present invention is selected the Radix Arnebiae (Radix Lithospermi) removing heat from blood and promoting blood circulation, the detoxifcation rash; The Cornu Saigae Tataricae suppressing the hyperactive liver to relieve the wind syndrome, heat-clearing and toxic substances removing, liver heat removing and eyesight improving; The Radix Et Rhizoma Rhei heat and toxic materials clearing away, clearing away heat-fire, removing pathogenic heat from blood and toxic substance from the body, blood circulation promoting and blood stasis dispelling; Radix Rehmanniae clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting; The Zaocys dispelling, collateral-activating; Periostracum Cicadae dispelling wind heat, rash, endogenous wind stopping relieving convulsion; The Sanguis Draxonis blood circulation promoting and blood stasis dispelling; Scorpio detoxifcation relieving convulsion, removing obstruction in the collateral to relieve pain.
The present invention treats psoriatic Chinese medicine, made by following materials of weight proportions medicine: Radix Arnebiae (Radix Lithospermi) 15-20%, Cornu Saigae Tataricae 2-5%, Radix Et Rhizoma Rhei (processed) 5-10%, Radix Rehmanniae 25-30%, Zaocys 25-30%, Periostracum Cicadae 5-10%, Sanguis Draxonis 5-10%, Scorpio 5-10%, the crude drug sum is 100%.
Crude drug is preferred: Radix Arnebiae (Radix Lithospermi) 13%, Cornu Saigae Tataricae 3%, Radix Et Rhizoma Rhei (processed) 7%, the Radix Rehmanniae 28%, Zaocys 28%, Periostracum Cicadae 7%, Sanguis Draxonis 7%, Scorpio 7%.
Preparation method of the present invention is that above-mentioned materials of weight proportions medicine pulverize is made powder.Instructions of taking: every day three times, the morning, noon and afternoon take, each 4 grams.Also the present invention can be prepared into decoction and pill, decoction potion every day is taken sooner or later; Pill every day three times, each 8 grams.
The compatible effect of playing expelling wind and clearing away heat, removing pathogenic heat from blood and toxic substance from the body, disperse blood stasis and dredge collateral altogether of crude drug of the present invention, and without any side effects, and effect stability does not recur.
The specific embodiment
With crude drug Radix Arnebiae (Radix Lithospermi) 10 gram, Cornu Saigae Tataricae 2 grams, Radix Et Rhizoma Rhei (processed) 5 grams, the Radix Rehmanniae 20 grams, Zaocys 20 grams, Periostracum Cicadae 5 grams, Sanguis Draxonis 5 grams, Scorpio 5 grams, be ground into powder and make powder and promptly get the present invention and treat psoriatic Chinese medicine.
Treatment by Chinese herbs psoriatic's of the present invention clinical trial
1. physical data
Accept patient's 100 examples for medical treatment, wherein male 67 examples, women 33 examples, the age is 5-58 year, above patient is homeliness type.
2. diagnostic criteria
Can be divided into four types according to the observation of psoriasis outward appearance: homeliness type, erythrodermic, arthrosis type, pustule type.Clinical the most common with homeliness type, can be divided into for three phases, promptly carry out phase, resting stage, catagen.Clinical diagnosis characteristics performance: cover the silvery white squama of multilamellar on the erythema,, deviate from the shinny semi-transparent film of one deck pale red, mark thin film, sieve shape petechia is arranged with the squama blade coating.Pathological manifestations parakeratosis is diagnosis basis.
The phase of carrying out, characteristics are that new skin lesion constantly occurs, and original skin lesion constantly enlarges, acute stage the skin lesion inflammation apparent in view, often show as cerise, be coated with above loose, come off easily silvery white squama, the periphery of skin lesion often have one the circle blush.
Also claim stable phase resting stage, do not have newborn erythra, or less, and inflammation is not obvious, and blush alleviates, and the course of disease is long.
3. Therapeutic Method
Every day three times, oral the present invention treats psoriatic Chinese powder medicine, each 4 grams.The stadium treatment was an observation caliber with 1-4 month.
4. curative effect determinate standard
Cure: skin lesion disappears, and the skin full recovery is normal.Produce effects: skin lesion disappears 70%～80%, and skin is most of to recover normal, only stays a little drop shape skin lesion.Invalid: taking medicine did not have significant change in 20 days.
5. result
Cure: 90 examples; Produce effects: 8 examples; Invalid: 2 examples.Cure rate reaches 90%, and total effective rate reaches 98%.
The Chinese medicine of the present invention all skin lesion of on average taking medicine begin to disappear, the shortest person took effect in 3 days, slow person took effect in 21 days, general 30 days left and right sides skin lesion of patient flatten smooth, continue to take medicine and consolidated in 30 days and can cure, have a routine patient to recur, continue medication and cured in 15 days because of humidity, so far not recurrence, all the other patients follow up a case by regular visits to not recurrence.
Claims (2)
1, the psoriatic Chinese medicine of a kind of treatment is characterized in that it is formulated by following materials of weight proportions medicine Radix Arnebiae (Radix Lithospermi) 15-20%, Cornu Saigae Tataricae 2-5%, Radix Et Rhizoma Rhei (processed) 5-10%, Radix Rehmanniae 25-30%, Zaocys 25-30%, Periostracum Cicadae 5-10%, Sanguis Draxonis 5-10%, Scorpio 5-10%.
2, the psoriatic Chinese medicine of the described treatment of root a tree name claim 1 is characterized in that: described crude drug Radix Arnebiae (Radix Lithospermi) 10 grams, Cornu Saigae Tataricae 2 grams, Radix Et Rhizoma Rhei (processed) 5 grams, the Radix Rehmanniae 20 grams, Zaocys 20 grams, Periostracum Cicadae 5 grams, Sanguis Draxonis 5 grams, Scorpio 5 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100440258A CN1301736C (en) | 2004-11-07 | 2004-11-07 | Poriasis treating Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100440258A CN1301736C (en) | 2004-11-07 | 2004-11-07 | Poriasis treating Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1634275A CN1634275A (en) | 2005-07-06 |
| CN1301736C true CN1301736C (en) | 2007-02-28 |
Family
ID=34845952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100440258A Expired - Fee Related CN1301736C (en) | 2004-11-07 | 2004-11-07 | Poriasis treating Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1301736C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101049341B (en) * | 2007-05-16 | 2011-11-09 | 长春同春堂皮肤病医院 | Chinese traditional medicine preparation for treating psoriasis |
| CN101496861B (en) * | 2009-02-28 | 2011-03-23 | 林海 | Traditional Chinese medicine for treating psoriasis |
| WO2016181355A1 (en) * | 2015-05-14 | 2016-11-17 | Roberto Logi | Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161203A (en) * | 1996-12-19 | 1997-10-08 | 吴大化 | Prepns. for treating psoriasis |
| CN1237453A (en) * | 1999-04-20 | 1999-12-08 | 朱花兰 | Snake scorpion skin-nourishing capsule |
-
2004
- 2004-11-07 CN CNB2004100440258A patent/CN1301736C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161203A (en) * | 1996-12-19 | 1997-10-08 | 吴大化 | Prepns. for treating psoriasis |
| CN1237453A (en) * | 1999-04-20 | 1999-12-08 | 朱花兰 | Snake scorpion skin-nourishing capsule |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1634275A (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6027728A (en) | Herbal skin regeneration composition and method | |
| CN100364589C (en) | A Chinese medicine for treating psoriasis | |
| CN102302661A (en) | Chinese medicinal composition for treating skin diseases | |
| CN1267146C (en) | Psoriasis-treating composition | |
| CN102319397A (en) | Chinese medicinal decoction for treating chronic pelvic inflammatory disease with clystering method | |
| CN1301736C (en) | Poriasis treating Chinese medicine | |
| CN101897871A (en) | Traditional Chinese medicine for treating psora | |
| CN1531950A (en) | Plaster medicine composition with multiple purpose for treating affection pain due to dampness | |
| CN1883642A (en) | Medicine for treating mammary glands hyperplasia | |
| CN1915385A (en) | Medication of medical broth for treating urethritis in type of hematuria, and preparation method | |
| CN101229239B (en) | Chinese traditional medicine for treating psoriasis | |
| CN101496861B (en) | Traditional Chinese medicine for treating psoriasis | |
| CN101940699B (en) | Traditional Chinese medicine for assisting in treating liver cancer | |
| CN101244136B (en) | Beauty treatment traditional Chinese medicine preparation for treating acne and preparation method | |
| CN104840507A (en) | Chinese medicinal ointment for treating face acne or comedo and preparation method | |
| CN1294961C (en) | Oral liquid for curing myocardial ischemia and process for preparing the same | |
| CN1709408A (en) | Medicine for treating anaphylactoid purpura | |
| CN104274540B (en) | Chinese medicine composition, preparation method and use containing tripterygium wilfordii | |
| CN1214804C (en) | Chinese medicine for treating face acne | |
| CN1919290A (en) | Decoction medicine for treating urethritis of lumbago type and its preparing process | |
| CN1915356A (en) | Medication of medical broth for treating urethritis, and preparation method | |
| CN101797330B (en) | Lipid regulating and meridians activating capsule | |
| CN105853556A (en) | Medicine for treating fungal, viral and bacterial skin disease and sexual skin disease | |
| CN111450223A (en) | Acne cream | |
| CN1255179C (en) | Medicine of cleanness without fleckiness and ringworm |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |